AZD3293

AZD3293 : Inhibitor of BACE1, BACE2

Structure

Information

  • BACE1
  • BACE2
  • Inhibitor
  • up to 100 nM

In Vitro Validations

Uniprot ID: P56817
Target Class: Enzyme
Target SubClass: Peptidase
Potency: Ki
Potency Value: 0.4 nM
Potency Assay: TR-FRET assays
PDB ID for probe-target interaction (3D structure): --
Target aliases:
Beta-secretase 1, KIAA1149, BACE, BACE1, BACE1_HUM ...

DOI Reference: 10.3233/JAD-150834

Uniprot ID: P56817
Target Class: Enzyme
Target SubClass: Peptidase
Potency: IC50
Potency Value: 0.6 nM
Potency Assay: TR-FRET assay
PDB ID for probe-target interaction (3D structure): --
Target aliases:
Beta-secretase 1, KIAA1149, BACE, BACE1, BACE1_HUM ...

DOI Reference: 10.3233/JAD-150834

Uniprot ID: P56817
Target Class: Enzyme
Target SubClass: Peptidase
Potency: T 1/2
Potency Value: 9 h
Potency Assay: binding assay, Bioacore
PDB ID for probe-target interaction (3D structure): --
Target aliases:
Beta-secretase 1, KIAA1149, BACE, BACE1, BACE1_HUM ...

DOI Reference: 10.3233/JAD-150834

In Cell Validations

In Vivo Data

No in Vivo Validations

Off-Target Selectivity Assesments

Potency assay (off target): Selective against hCathepsin D (Ki 3867 nm/ IC50 16100 nM) and gamma-Secretase Notch Cleavage (IC50 >25000 nM)
I have extra information to add

SERP ratings and comments


SERP Ratings

In Cell Rating

(last updated: 31 Jul 2024 )

SERP+ Ratings

In Cell Rating

SERP+ Comments:

AZD3293 is a highly potent inhibitor of both BACE1 (IC50: 0.6 nM in vitro) and BACE2 AM-6494 (IC50: 0.9 nM in vitro) with high selectivity over hCathepsin D (IC50: 16100 nM) and hERG (IC50: 4700nM). A not further described panel of more than 350 in vitro assays covering receptors, ion channels, transporters, kinases and other enzymes suggests a 1,000-fold selectivity against BACE1/2. In vivo studies in mice, guinea pigs, dogs and humans (AMARANTH (NCT02245737)) have been performed. Other probes with selectivity against BACE1 over BACE2 like AM-6494 are already available and should be considered if this selectivity is desired.

(last updated: 23 Sept 2024 )